Drug Shortage Report for SABRIL
| Report ID | 267944 |
| Drug Identification Number | 02068036 |
| Brand name | SABRIL |
| Common or Proper name | vigabatrin powder for oral solution |
| Company Name | LUNDBECK PHARMACEUTICALS LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | VIGABATRIN |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | ORAL ORAL |
| Packaging size | Cartons of 50 |
| ATC code | N03AG |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2025-09-26 |
| Actual start date | 2025-09-26 |
| Estimated end date | 2026-01-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-09-27 |
| Company comments | The shortage is due to packaging delays (unrelated to product quality). |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | SIX PARKWAY NORTH, SUITE 400 DEERFIELD, ILLINOIS UNITED STATES 60015 |
| Company contact information | 1-866-880-4636 canadamedicalinformation@lundbeck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-09-27 | English | Compare |
| v2 | 2025-09-26 | French | Compare |
| v1 | 2025-09-26 | English | Compare |
Showing 1 to 3 of 3